home / stock / adk:cc / adk:cc news

ADK:CC News and Press, Diagnos Inc.

Stock Information
Company Name: Diagnos Inc.
Stock Symbol: ADK:CC
Market: TSXVC
Website: diagnos.ca
Menu
ADK:CC ADK:CC Quote ADK:CC Short ADK:CC News ADK:CC Articles ADK:CC Message Board
Get ADK:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
ADK:CC - DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

BROSSARD, Quebec, March 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence ( AI ) techniques...
ADK:CC - DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Artificial...

ADK:CC - DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Art...

ADK:CC - InvestorNewsBreaks - Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF) (FWB: 4D4A) Engages IBN for Corporate Communications and Awareness 

2026-01-16 09:40:01 ET Disseminated on behalf of Diagnos Inc. and may include paid advertising. Diagnos (TSX Venture: ADK) (OTCQB: DGNOF) (FWB: 4D4A) , a pioneer in early detection of critical health issues using Artificial Intelligence-bas...
ADK:CC - DIAGNOS Announces the Engagement of IBN

BROSSARD, Quebec, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announ...

ADK:CC - InvestorNewsBreaks - Diagnos Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) Provides Regulatory Update on CARA AI Platform

2026-01-13 10:25:00 ET This article has been disseminated on behalf of Diagnos Inc. and may include paid advertising. Diagnos (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) provided an update on the regulatory pathway for its CARA artificial intelligence platform for early detectio...

ADK:CC - DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

BROSSARD, Quebec, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence (AI) for the early detection of eye-related health issues, is plea...
ADK:CC - DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence (AI) for the early detection of eye-related health issues, is plea...

ADK:CC - Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital

Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Quebec, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSXV: ADK and OTCQB: DGNOF) is pleased to announce the su...

ADK:CC - Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Québec, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSXV: ADK and OTCQB: DGNOF) is pleased to announce t...
Next 10